Genomic Health (GHDX) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $74.5 million versus the consensus estimate of $74.03 million.
GUIDANCE:
Genomic Health sees FY2016 revenue of $320-335 million, versus the consensus of $328.8 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Cal-Maine Foods (CALM) PT Lowered to $80 at Stephens
- Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
